Simon C Robson Selected Research

Dextran Sulfate

7/2020	Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease.
1/2019	NTPDase1 and -2 are expressed by distinct cellular compartments in the mouse colon and differentially impact colonic physiology and function after DSS colitis.
11/2018	HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease.
11/2017	The ectonucleotidase ENTPD1/CD39 limits biliary injury and fibrosis in mouse models of sclerosing cholangitis.
1/2012	Evaluation of multimeric tyrosine-O-sulfate as a cytoprotectant in an in vivo model of acute myocardial infarction in pigs.
11/2005	Locally targeted cytoprotection with dextran sulfate attenuates experimental porcine myocardial ischaemia/reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Simon C Robson Research Topics

Disease

58	Inflammation (Inflammations) 07/2023 - 04/2002
38	Neoplasms (Cancer) 01/2023 - 01/2007
19	Reperfusion Injury 01/2022 - 03/2004
18	Fibrosis (Cirrhosis) 01/2023 - 01/2008
14	Thrombosis (Thrombus) 01/2021 - 04/2002
12	Colitis 01/2022 - 04/2005
12	Vascular System Injuries 03/2014 - 03/2004
11	Ischemia 01/2023 - 03/2004
10	Hypoxia (Hypoxemia) 01/2023 - 09/2003
8	Liver Cirrhosis (Hepatic Cirrhosis) 09/2022 - 01/2016
7	Myocardial Infarction 12/2022 - 11/2005
7	Crohn Disease (Crohn's Disease) 01/2022 - 05/2011
7	Sepsis (Septicemia) 10/2017 - 10/2008
7	Thrombocytopenia (Thrombopenia) 09/2014 - 01/2005
6	Hemorrhage 01/2023 - 07/2003
6	Neoplasm Metastasis (Metastasis) 01/2020 - 06/2011
6	Hepatitis 01/2019 - 09/2008
6	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 10/2012
5	Infections 01/2022 - 06/2003
5	Non-alcoholic Fatty Liver Disease 10/2021 - 01/2013
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 04/2005
4	Lung Injury 07/2023 - 06/2012
4	Pneumonia (Pneumonitis) 01/2021 - 01/2016
4	Infarction (Infarctions) 08/2014 - 10/2007
3	Heart Arrest (Cardiac Arrest) 01/2024 - 01/2023
3	Autoimmune Hepatitis 12/2023 - 06/2012
3	Hyperoxia 01/2023 - 12/2015
3	Pathologic Processes 01/2023 - 10/2012
3	Insulin Resistance 03/2016 - 09/2008
3	Thrombotic Microangiopathies 11/2015 - 07/2003
3	Necrosis 03/2015 - 08/2008
3	Colonic Neoplasms (Colon Cancer) 04/2013 - 06/2007
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012 - 10/2007
2	Stroke (Strokes) 05/2024 - 01/2018
2	Wounds and Injuries (Trauma) 07/2023 - 01/2023
2	Disease Progression 01/2023 - 06/2012
2	Hemolysis 01/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2013

Drug/Important Bio-Agent (IBA)

37	Adenosine Triphosphate (ATP)IBA 07/2023 - 04/2002
37	Adenosine (Adenocard)FDA LinkGeneric 07/2023 - 09/2003
27	NucleotidesIBA 12/2022 - 04/2002
16	triphosphoric acid (triphosphate)IBA 07/2023 - 04/2002
13	NucleosidesIBA 01/2022 - 04/2002
12	EnzymesIBA 07/2023 - 12/2008
12	Adenosine Diphosphate (ADP)IBA 10/2021 - 04/2002
11	Apyrase (ATP Diphosphatase)IBA 07/2020 - 03/2004
10	CytokinesIBA 07/2023 - 01/2008
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2003
9	Purinergic Receptors (Receptors, Purine)IBA 01/2021 - 11/2006
8	Oxygen (Dioxygen)IBA 07/2023 - 09/2003
8	Messenger RNA (mRNA)IBA 01/2023 - 09/2003
7	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2023 - 11/2006
7	CD39 antigenIBA 12/2022 - 10/2007
7	ectoATPaseIBA 08/2020 - 03/2006
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2011
6	5'-Nucleotidase (5' Nucleotidase)IBA 01/2022 - 12/2004
6	Dextran SulfateIBA 07/2020 - 11/2005
5	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2023 - 06/2015
5	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2012
5	Dextrans (Dextran)FDA Link 01/2022 - 04/2005
5	Adenosine Monophosphate (AMP)IBA 10/2021 - 12/2004
5	SodiumIBA 01/2019 - 05/2011
4	Therapeutic UsesIBA 01/2022 - 01/2018
4	InflammasomesIBA 01/2020 - 01/2014
4	Interleukin-10 (Interleukin 10)IBA 01/2018 - 08/2008
4	Adenine NucleotidesIBA 01/2016 - 09/2003
3	Complement System Proteins (Complement)IBA 01/2023 - 01/2012
3	Sulfonic AcidsIBA 01/2022 - 05/2011
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 04/2005
3	BilirubinIBA 01/2022 - 05/2017
3	Adenosine DeaminaseIBA 10/2021 - 10/2014
3	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 10/2021 - 07/2012
3	purineIBA 01/2019 - 12/2008
3	3,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA 01/2019 - 11/2017
3	CollagenIBA 01/2019 - 01/2008
3	LipidsIBA 01/2018 - 01/2013
3	Thromboplastin (Tissue Factor)IBA 01/2018 - 04/2006
3	Purinergic P2X7 ReceptorsIBA 10/2017 - 05/2013
3	Blood Coagulation Factors (Coagulation Factor)IBA 05/2017 - 06/2003
3	AnticoagulantsIBA 05/2017 - 11/2005
3	VLDL LipoproteinsIBA 03/2016 - 01/2013
3	Lipoproteins (Lipoprotein)IBA 01/2016 - 01/2013
3	Triglycerides (Triacylglycerol)IBA 01/2014 - 06/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2013 - 10/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2012 - 07/2003
2	ChemokinesIBA 07/2023 - 01/2023
2	Heme (Haem)IBA 01/2023 - 04/2005
2	Heterophile AntigensIBA 01/2023 - 04/2011
2	Heme Oxygenase-1IBA 09/2022 - 04/2005

Therapy/Procedure

27	Therapeutics 05/2024 - 07/2003
12	Transplantation 01/2021 - 05/2004
8	Heterologous Transplantation (Xenotransplantation) 01/2022 - 06/2003
6	Liver Transplantation 01/2019 - 11/2005
5	Drug Therapy (Chemotherapy) 01/2023 - 04/2008
5	Immunotherapy 01/2023 - 01/2017
5	Ligation 09/2022 - 10/2008
3	Artificial Respiration (Mechanical Ventilation) 01/2023 - 12/2017
3	Punctures 10/2017 - 10/2008
2	Resuscitation 01/2024 - 01/2023
2	Radiotherapy 01/2023 - 01/2020